About
Drug Discovery
Eidogen-Sertanty is dedicated to improving healthspan, medicine, and general well-being. For over 20-years, Eidogen-Sertanty has helped to expedite the discovery and development of many new, safer medicines through collaborative project team engagement, innovative software technology, and knowledgebases. Eidogen-Sertanty's wide ranging capabilities bridge the gap between biology and chemistry which accelerates the drug discovery and development process.
Since 2003, we have worked with every top pharmaceutical and biopharmaceutical company in the world across the alphabet of chronic and acute disease. Through our product and service offerings, Eidogen-Sertanty proudly has helped companies make advances in numerous disease areas including cancer, AIDS, arthritis, general infection, and pain.
Our major discovery informatics platforms TIP™, ChIP™, and Kinase Knowledgebase™ allow our pharmaceutical clients and partners to leverage public and proprietary chemical and structural knowledge to substantially improve the overall efficiency of the drug discovery cycle from hit to lead, increasing the odds and lowering the costs of successfully developing novel, safe, and effective medicines.
Our DirectDesign™ Discovery Service combines all of our proprietary technologies for the directed de novo design of lead compounds and target-focused virtual libraries. Our biotechnology and pharmaceutical clients utilize DirectDesign to fully exploit the complete spectrum of Eidogen-Sertanty's knowledge-driven discovery informatics capabilities on a project-by-project basis.